{"id":70333,"date":"2020-09-18T03:00:00","date_gmt":"2020-09-18T03:00:00","guid":{"rendered":"https:\/\/icrowdnewswire.com\/?p=2729161"},"modified":"2020-09-18T03:00:00","modified_gmt":"2020-09-18T03:00:00","slug":"therapeutic-drug-monitoring-market-to-reach-2-0-billion-by-2025","status":"publish","type":"post","link":"https:\/\/ipsnews.net\/business\/2020\/09\/18\/therapeutic-drug-monitoring-market-to-reach-2-0-billion-by-2025\/","title":{"rendered":"Therapeutic Drug Monitoring Market to Reach $2.0 billion by 2025"},"content":{"rendered":"<p>According to the new market research report<strong>&#8220;<\/strong><strong>Therapeutic Drug Monitoring Marketby Product (Equipment (Immunoassay Analyzers), Consumables), Technology (Immunoassays, Chromatography-MS), Class of Drugs (Antibiotic Drugs, Bronchodilator Drugs), End User &#8211; Global Forecast to 2025&#8243;,<\/strong>published by MarketsandMarkets<img decoding=\"async\" src=\"https:\/\/s.w.org\/images\/core\/emoji\/13.0.0\/72x72\/2122.png\" alt=\"&trade;\" class=\"wp-smiley\" style=\"height: 1em; max-height: 1em;\" \/>,<strong><\/strong><strong>the<\/strong>Therapeutic Drug Monitoring Marketis projected to reach<span class=\"xn-money\">USD 2.0 billion<\/span>by 2025 from<span class=\"xn-money\">USD 1.4 billion<\/span>in 2020, at a CAGR of 6.9% from 2020 to 2025.<\/p>\n<p><strong>Download PDF Brochure:<\/strong><br \/>\n<a href=\"https:\/\/www.marketsandmarkets.com\/pdfdownloadNew.asp?id=155350443&amp;utm_source=prnewswire&amp;utm_medium=referral&amp;utm_campaign=paidpr\" target=\"_blank\" rel=\"nofollow noopener noreferrer\">https:\/\/www.marketsandmarkets.com\/pdfdownloadNew.asp?id=155350443<\/a><\/p>\n<p>The TDM Market growth is largely driven by factors such as the rising number of organ transplant procedures, the use of TDM across various therapeutic fields, the increasing preference for precision medicine, a growing focus on R&amp;D related to TDM, and technological advancements in immunoassay instruments. Increasing adoption in the treatment of autoimmune diseases is expected to provide a wide range of growth opportunities for players in the market.<\/p>\n<p><img decoding=\"async\" class=\"aligncenter\" style=\"margin-left: auto; margin-right: auto;\" src=\"https:\/\/pressrelease.icrowdnewswire.com\/assets\/source\/users\/1902\/therapeutic-drug-monitoring-market11.jpg?1600329441663\" alt=\"therapeutic-drug-monitoring-market11\" \/><\/p>\n<p><strong>Consumables is expected to hold the largest share of the therapeutic drug monitoring market in 2020<\/strong><\/p>\n<p>On the basis of product, the market is segmented into equipment and consumables. In 2019, consumables segment accounted for the largest market share, primarily due to the repeat purchases of kits and reagents and the increasing number of immunoassay tests being performed across the globe.<\/p>\n<p><em>Browsein-depth TOC on<\/em><strong>&#8220;<\/strong><a href=\"https:\/\/www.marketsandmarkets.com\/Market-Reports\/therapeutic-drug-monitoring-market-155350443.html\" target=\"_blank\" rel=\"nofollow noopener noreferrer\">Therapeutic Drug Monitoring Market<\/a><strong>&#8220;<\/strong><\/p>\n<p><strong>288 &ndash; Tables<br \/>\n<\/strong><strong>35 &ndash; Figures<br \/>\n<\/strong><strong>241 &ndash; Pages<\/strong><\/p>\n<p><strong>Immunoassays is expected to hold the largest share of the market in 2020<\/strong><\/p>\n<p>Based on technology, the TDM Market is segmented into immunoassays and chromatography-MS. In 2019, immunoassays segment accounted for the largest market share, due to the increasing incidence of chronic and infectious diseases and technological innovation.<\/p>\n<p><strong>Antiepileptic drugs is expected to hold the largest share of the<\/strong><strong>therapeutic drug monitoring market in 2020<\/strong><\/p>\n<p>On the basis of class of drug, the market is segmented into antiepileptic drugs, antibiotic drugs, immunosuppressant drugs, antiarrhythmic drugs, bronchodilator drugs, psychoactive agents, and other drugs. During 2019, antiepileptic drugs held the largest share among the class of drug due to the high complexity and heterogeneity of epilepsy, lack of biological markers or specific clinical signs aside from the frequency of seizures to assess treatment efficacy or toxicity, and the highly complex pharmacokinetics of these drugs.<\/p>\n<p><strong>Hospital laboratories segment commanded the largest share of the TDM Market in 2019<\/strong><\/p>\n<p>By end user, the market is segmented into hospital laboratories, commercial &amp; private laboratories, and other end users. Hospital laboratories accounted for the largest share of the market in 2019. The large share of this segment can be attributed to factors such as the availability of advanced healthcare facilities in hospitals and the rising incidences of chronic diseases.<\/p>\n<p><strong>Request Sample Report:<br \/>\n<a href=\"https:\/\/www.marketsandmarkets.com\/requestsampleNew.asp?id=155350443\">https:\/\/www.marketsandmarkets.com\/requestsampleNew.asp?id=155350443<\/a><\/strong><\/p>\n<p><strong><span class=\"xn-location\">North America<\/span>commanded the largest share of the therapeutic drug monitoring market in 2019.<\/strong><\/p>\n<p>On the basis of region, the market is segmented into<span class=\"xn-location\">North America<\/span>,<span class=\"xn-location\">Europe<\/span>,<span class=\"xn-location\">Asia Pacific<\/span>,<span class=\"xn-location\">Latin America<\/span>, and the<span class=\"xn-location\">Middle East<\/span>&amp;<span class=\"xn-location\">Africa<\/span>. In 2019,<span class=\"xn-location\">North America<\/span>commanded the largest share of the market. Increasing per capita healthcare expenditure and the presence of technologically advanced healthcare infrastructure in the region, coupled with initiatives taken by different government associations, are anticipated to boost the market growth in the region.<\/p>\n<p>The major players operating in this therapeutic drug monitoring market are Abbott Laboratories (U.S.), F. Hoffmann-La Roche (<span class=\"xn-location\">Switzerland<\/span>), Siemens Healthineers (<span class=\"xn-location\">Germany<\/span>), Thermo Fisher Scientific (U.S.), Danaher Corporation (U.S.), Bio-Rad Laboratories (U.S.), bioMrieux (<span class=\"xn-location\">France<\/span>), BHLMANN Laboratories (<span class=\"xn-location\">Switzerland<\/span>), SEKISUI MEDICAL (<span class=\"xn-location\">Japan<\/span>), Randox Laboratories (<span class=\"xn-location\">Ireland<\/span>), DiaSystem Scandinavia AB (<span class=\"xn-location\">Sweden<\/span>), Cambridge Life Sciences Limited (<span class=\"xn-location\">United Kingdom<\/span>), ARK Diagnostics, Inc. (U.S.), Chromsystems Instruments &amp; Chemicals GmbH (<span class=\"xn-location\">Germany<\/span>), Grifols (<span class=\"xn-location\">Spain<\/span>), Exagen Inc. (U.S.), Theradiag (<span class=\"xn-location\">France<\/span>), R-Biopharm AG (<span class=\"xn-location\">Germany<\/span>), apDia Group (<span class=\"xn-location\">Belgium<\/span>), BioTeZ Berlin-Buch GmbH (<span class=\"xn-location\">Belgium<\/span>), Eagle Biosciences Inc. (U.S.), JASEM Laboratory Systems and Solutions A.S (<span class=\"xn-location\">Turkey<\/span>), Aalto Scientific (U.S.), Immundiagnostik AG (<span class=\"xn-location\">Germany<\/span>), and UTAK (U.S.).<\/p>\n<p class=\"tags\">Tags: <a href=\"https:\/\/icrowdnewswire.com\/tag\/therapeutic-drug-monitoring-market\/\" rel=\"tag\">Therapeutic Drug Monitoring market<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/tag\/therapeutic-drug-monitoring-industry\/\" rel=\"tag\">therapeutic drug Monitoring industry<\/a><\/p>\n<div><strong>See Campaign: <\/strong><a href=\"https:\/\/www.marketsandmarkets.com\/Market-Reports\/therapeutic-drug-monitoring-market-155350443.html\" target=\"_blank\">https:\/\/www.marketsandmarkets.com\/Market-Reports\/therapeutic-drug-monitoring-market-155350443.html<\/a><br \/><b>Contact Information:<\/b><br \/>Mr. Ashish Mehra<br \/>\nMarketsandMarkets<img decoding=\"async\" src=\"https:\/\/s.w.org\/images\/core\/emoji\/13.0.0\/72x72\/2122.png\" alt=\"&trade;\" class=\"wp-smiley\" style=\"height: 1em; max-height: 1em;\" \/> INC.<br \/>\n630 Dundee Road<br \/>\nSuite 430<br \/>\nNorthbrook, IL 60062<br \/>\nUSA : 1-888-600-6441<\/p>\n<p><b>Tags:<\/b><br \/><a href=\"\"><\/a>, <a href=\"https:\/\/icrowdnewswire.com\/category\/ips\/\" rel=\"category tag\">IPS<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/category\/reportedtimes\/\" rel=\"category tag\">Reportedtimes<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/category\/news-category\/icn_internal_distribution\/\" rel=\"category tag\">iCN Internal Distribution<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/category\/news-category\/extended-distribution\/\" rel=\"category tag\">Extended Distribution<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/category\/news-category\/research-newswire\/\" rel=\"category tag\">Research Newswire<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/category\/language\/english\/\" rel=\"category tag\">English<\/a><\/p>\n<p><img loading=\"lazy\" decoding=\"async\" src=\"\" alt=\"image\" width=\"400\" height=\"300\" class=\"cwdfimg\" \/><\/div>\n<div>\n<h3>Contact Information:<\/h3>\n<p>Mr. Ashish Mehra<br \/>\nMarketsandMarkets\u2122 INC.<br \/>\n630 Dundee Road<br \/>\nSuite 430<br \/>\nNorthbrook, IL 60062<br \/>\nUSA : 1-888-600-6441<\/p>\n<\/p><\/div>\n","protected":false},"excerpt":{"rendered":"<p>According to the new market research report&nbsp;&ldquo;Therapeutic Drug Monitoring Market&nbsp;by Product (Equipment (Immunoassay Analyzers), Consumables), Technology (Immunoassays, Chromatography-MS), Class of Drugs (Antibiotic Drugs, Bronchodilator Drugs), End User &ndash; Global Forecast to 2025&Prime;,&nbsp;published by MarketsandMarkets&trade;,&nbsp;the&nbsp;Therapeutic Drug Monitoring Market&nbsp;is projected to reach&nbsp;USD 2.0 billion&nbsp;by 2025 from&nbsp;USD 1.4 billion&nbsp;in 2020, at a CAGR of 6.9% from 2020 to &hellip; <a href=\"https:\/\/icrowdnewswire.com\/2020\/09\/17\/therapeutic-drug-monitoring-market-to-reach-2-0-billion-by-2025\/\">Continue reading <span>Therapeutic Drug Monitoring Market to Reach $2.0 billion by 2025<\/span><\/a> <a href=\"https:\/\/ipsnews.net\/business\/2020\/09\/18\/therapeutic-drug-monitoring-market-to-reach-2-0-billion-by-2025\/\" class=\"more-link\">Continue Reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":44,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[3,5,67,57,64,4],"tags":[],"class_list":["post-70333","post","type-post","status-publish","format-standard","hentry","category-english","category-extended-distribution","category-icn-internal-distribution","category-ips","category-reportedtimes","category-research-newswire"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v24.9 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Therapeutic Drug Monitoring Market to Reach $2.0 billion by 2025 - Business<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ipsnews.net\/business\/2020\/09\/18\/therapeutic-drug-monitoring-market-to-reach-2-0-billion-by-2025\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Therapeutic Drug Monitoring Market to Reach $2.0 billion by 2025 - Business\" \/>\n<meta property=\"og:description\" content=\"According to the new market research report&nbsp;&ldquo;Therapeutic Drug Monitoring Market&nbsp;by Product (Equipment (Immunoassay Analyzers), Consumables), Technology (Immunoassays, Chromatography-MS), Class of Drugs (Antibiotic Drugs, Bronchodilator Drugs), End User &ndash; Global Forecast to 2025&Prime;,&nbsp;published by MarketsandMarkets&trade;,&nbsp;the&nbsp;Therapeutic Drug Monitoring Market&nbsp;is projected to reach&nbsp;USD 2.0 billion&nbsp;by 2025 from&nbsp;USD 1.4 billion&nbsp;in 2020, at a CAGR of 6.9% from 2020 to &hellip; Continue reading Therapeutic Drug Monitoring Market to Reach $2.0 billion by 2025 Continue Reading &rarr;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ipsnews.net\/business\/2020\/09\/18\/therapeutic-drug-monitoring-market-to-reach-2-0-billion-by-2025\/\" \/>\n<meta property=\"og:site_name\" content=\"Business\" \/>\n<meta property=\"article:published_time\" content=\"2020-09-18T03:00:00+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/s.w.org\/images\/core\/emoji\/13.0.0\/72x72\/2122.png\" \/>\n<meta name=\"author\" content=\"SamirS\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"SamirS\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/ipsnews.net\/business\/2020\/09\/18\/therapeutic-drug-monitoring-market-to-reach-2-0-billion-by-2025\/\",\"url\":\"https:\/\/ipsnews.net\/business\/2020\/09\/18\/therapeutic-drug-monitoring-market-to-reach-2-0-billion-by-2025\/\",\"name\":\"Therapeutic Drug Monitoring Market to Reach $2.0 billion by 2025 - Business\",\"isPartOf\":{\"@id\":\"https:\/\/ipsnews.net\/business\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/ipsnews.net\/business\/2020\/09\/18\/therapeutic-drug-monitoring-market-to-reach-2-0-billion-by-2025\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/ipsnews.net\/business\/2020\/09\/18\/therapeutic-drug-monitoring-market-to-reach-2-0-billion-by-2025\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/s.w.org\/images\/core\/emoji\/13.0.0\/72x72\/2122.png\",\"datePublished\":\"2020-09-18T03:00:00+00:00\",\"author\":{\"@id\":\"https:\/\/ipsnews.net\/business\/#\/schema\/person\/c8136aea533df6c8ecc6c0ac1fef1ca1\"},\"breadcrumb\":{\"@id\":\"https:\/\/ipsnews.net\/business\/2020\/09\/18\/therapeutic-drug-monitoring-market-to-reach-2-0-billion-by-2025\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/ipsnews.net\/business\/2020\/09\/18\/therapeutic-drug-monitoring-market-to-reach-2-0-billion-by-2025\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/ipsnews.net\/business\/2020\/09\/18\/therapeutic-drug-monitoring-market-to-reach-2-0-billion-by-2025\/#primaryimage\",\"url\":\"https:\/\/s.w.org\/images\/core\/emoji\/13.0.0\/72x72\/2122.png\",\"contentUrl\":\"https:\/\/s.w.org\/images\/core\/emoji\/13.0.0\/72x72\/2122.png\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/ipsnews.net\/business\/2020\/09\/18\/therapeutic-drug-monitoring-market-to-reach-2-0-billion-by-2025\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/ipsnews.net\/business\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Therapeutic Drug Monitoring Market to Reach $2.0 billion by 2025\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/ipsnews.net\/business\/#website\",\"url\":\"https:\/\/ipsnews.net\/business\/\",\"name\":\"Business\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/ipsnews.net\/business\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/ipsnews.net\/business\/#\/schema\/person\/c8136aea533df6c8ecc6c0ac1fef1ca1\",\"name\":\"SamirS\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/ipsnews.net\/business\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/57f95c6f961880f5bc4a8db448e8e3ba37f42f025b51de3369f698887f88c645?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/57f95c6f961880f5bc4a8db448e8e3ba37f42f025b51de3369f698887f88c645?s=96&d=mm&r=g\",\"caption\":\"SamirS\"},\"sameAs\":[\"https:\/\/icrowdnewswire.com\/fc\"],\"url\":\"https:\/\/ipsnews.net\/business\/author\/samirs\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Therapeutic Drug Monitoring Market to Reach $2.0 billion by 2025 - Business","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ipsnews.net\/business\/2020\/09\/18\/therapeutic-drug-monitoring-market-to-reach-2-0-billion-by-2025\/","og_locale":"en_US","og_type":"article","og_title":"Therapeutic Drug Monitoring Market to Reach $2.0 billion by 2025 - Business","og_description":"According to the new market research report&nbsp;&ldquo;Therapeutic Drug Monitoring Market&nbsp;by Product (Equipment (Immunoassay Analyzers), Consumables), Technology (Immunoassays, Chromatography-MS), Class of Drugs (Antibiotic Drugs, Bronchodilator Drugs), End User &ndash; Global Forecast to 2025&Prime;,&nbsp;published by MarketsandMarkets&trade;,&nbsp;the&nbsp;Therapeutic Drug Monitoring Market&nbsp;is projected to reach&nbsp;USD 2.0 billion&nbsp;by 2025 from&nbsp;USD 1.4 billion&nbsp;in 2020, at a CAGR of 6.9% from 2020 to &hellip; Continue reading Therapeutic Drug Monitoring Market to Reach $2.0 billion by 2025 Continue Reading &rarr;","og_url":"https:\/\/ipsnews.net\/business\/2020\/09\/18\/therapeutic-drug-monitoring-market-to-reach-2-0-billion-by-2025\/","og_site_name":"Business","article_published_time":"2020-09-18T03:00:00+00:00","og_image":[{"url":"https:\/\/s.w.org\/images\/core\/emoji\/13.0.0\/72x72\/2122.png","type":"","width":"","height":""}],"author":"SamirS","twitter_card":"summary_large_image","twitter_misc":{"Written by":"SamirS","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/ipsnews.net\/business\/2020\/09\/18\/therapeutic-drug-monitoring-market-to-reach-2-0-billion-by-2025\/","url":"https:\/\/ipsnews.net\/business\/2020\/09\/18\/therapeutic-drug-monitoring-market-to-reach-2-0-billion-by-2025\/","name":"Therapeutic Drug Monitoring Market to Reach $2.0 billion by 2025 - Business","isPartOf":{"@id":"https:\/\/ipsnews.net\/business\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ipsnews.net\/business\/2020\/09\/18\/therapeutic-drug-monitoring-market-to-reach-2-0-billion-by-2025\/#primaryimage"},"image":{"@id":"https:\/\/ipsnews.net\/business\/2020\/09\/18\/therapeutic-drug-monitoring-market-to-reach-2-0-billion-by-2025\/#primaryimage"},"thumbnailUrl":"https:\/\/s.w.org\/images\/core\/emoji\/13.0.0\/72x72\/2122.png","datePublished":"2020-09-18T03:00:00+00:00","author":{"@id":"https:\/\/ipsnews.net\/business\/#\/schema\/person\/c8136aea533df6c8ecc6c0ac1fef1ca1"},"breadcrumb":{"@id":"https:\/\/ipsnews.net\/business\/2020\/09\/18\/therapeutic-drug-monitoring-market-to-reach-2-0-billion-by-2025\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ipsnews.net\/business\/2020\/09\/18\/therapeutic-drug-monitoring-market-to-reach-2-0-billion-by-2025\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/ipsnews.net\/business\/2020\/09\/18\/therapeutic-drug-monitoring-market-to-reach-2-0-billion-by-2025\/#primaryimage","url":"https:\/\/s.w.org\/images\/core\/emoji\/13.0.0\/72x72\/2122.png","contentUrl":"https:\/\/s.w.org\/images\/core\/emoji\/13.0.0\/72x72\/2122.png"},{"@type":"BreadcrumbList","@id":"https:\/\/ipsnews.net\/business\/2020\/09\/18\/therapeutic-drug-monitoring-market-to-reach-2-0-billion-by-2025\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ipsnews.net\/business\/"},{"@type":"ListItem","position":2,"name":"Therapeutic Drug Monitoring Market to Reach $2.0 billion by 2025"}]},{"@type":"WebSite","@id":"https:\/\/ipsnews.net\/business\/#website","url":"https:\/\/ipsnews.net\/business\/","name":"Business","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ipsnews.net\/business\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/ipsnews.net\/business\/#\/schema\/person\/c8136aea533df6c8ecc6c0ac1fef1ca1","name":"SamirS","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/ipsnews.net\/business\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/57f95c6f961880f5bc4a8db448e8e3ba37f42f025b51de3369f698887f88c645?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/57f95c6f961880f5bc4a8db448e8e3ba37f42f025b51de3369f698887f88c645?s=96&d=mm&r=g","caption":"SamirS"},"sameAs":["https:\/\/icrowdnewswire.com\/fc"],"url":"https:\/\/ipsnews.net\/business\/author\/samirs\/"}]}},"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/posts\/70333","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/users\/44"}],"replies":[{"embeddable":true,"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/comments?post=70333"}],"version-history":[{"count":0,"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/posts\/70333\/revisions"}],"wp:attachment":[{"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/media?parent=70333"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/categories?post=70333"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/tags?post=70333"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}